Anticoagulation in COVID-19: current concepts and controversies.

Chandra, Atanu; Chakraborty, Uddalak; Ghosh, Shrestha; Dasgupta, Sugata

Chandra, Atanu; Chakraborty, Uddalak; Ghosh, Shrestha; Dasgupta, Sugata.

Afiliación

Chandra A; Internal Medicine, RG Kar Medical College and Hospital, Kolkata, India chandraatanu123@gmail.com.
Chakraborty U; Neurology, Institute of Postgraduate Medical Education and Research, Bangur Institute of Neurology, Kolkata, West Bengal, India.
Ghosh S; Internal Medicine, RG Kar Medical College and Hospital, Kolkata, India.
Dasgupta S; Critical Care Medicine, RG Kar Medical College and Hospital, Kolkata, West Bengal, India.

Postgrad Med J ; 98(1159): 395-402, 2022 May.

Article en En | MEDLINE | ID: mdl-33850011

Asunto(s)

COVID-19; Tromboembolia; Tromboembolia Venosa; Cuidados Posteriores; Anticoagulantes/uso terapéutico; Humanos; Alta del Paciente; SARS-CoV-2; Tromboembolia/tratamiento farmacológico; Tromboembolia/etiología; Tromboembolia/prevención & control; Tromboembolia Venosa/etiología

Palabras clave

COVID-19; anticoagulation; internal medicine; thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia / Tromboembolia Venosa / COVID-19 Tipo de estudio: Etiology_studies / Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Postgrad Med J Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google